RIPK1 and Cognitive impairment: Ofengeim et al. (2017) found that RIP1 activation increased in the microglia of brains during Alzheimer’s disease. Inhibiting RIP1 activation alleviated neuroinflammation and cognitive impairments during Alzheimer’s disease (Ofengeim et al., 2017).